BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24082113)

  • 1. Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models.
    Yang S; Xiao Y; Kang D; Liu J; Li Y; Undheim EA; Klint JK; Rong M; Lai R; King GF
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17534-9. PubMed ID: 24082113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
    Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
    Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion of Ssm6a with a protein scaffold retains selectivity on Na
    Wang C; Shan B; Wang Q; Xu Q; Zhang H; Lei H
    Chem Biol Drug Des; 2017 Jun; 89(6):825-833. PubMed ID: 27896920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zhang F; Zhang C; Xu X; Zhang Y; Gong X; Yang Z; Zhang H; Tang D; Liang S; Liu Z
    J Biol Chem; 2019 May; 294(18):7324-7334. PubMed ID: 30804211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Toxin from Haplopelma lividum Selectively Inhibits the Na
    Meng P; Huang H; Wang G; Yang S; Lu Q; Liu J; Lai R; Rong M
    Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28035974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Synthesis, Proper Folding, Na
    Nicolas S; Zoukimian C; Bosmans F; Montnach J; Diochot S; Cuypers E; De Waard S; Béroud R; Mebs D; Craik D; Boturyn D; Lazdunski M; Tytgat J; De Waard M
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31234412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Closed-State Nav1.7 Blocker JZTX-34 Exhibits Analgesic Effects against Pain.
    Zeng X; Li P; Chen B; Huang J; Lai R; Liu J; Rong M
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29393892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
    Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
    PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.
    Zhang YX; Peng DZ; Zhang QF; Huang B; Yang QC; Tang DF; Chen MZ; Rong MQ; Liu ZH
    Acta Pharmacol Sin; 2019 Jul; 40(7):859-866. PubMed ID: 30382183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
    Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
    J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
    Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
    Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na
    Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD
    J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.
    Liu Z; Cai T; Zhu Q; Deng M; Li J; Zhou X; Zhang F; Li D; Li J; Liu Y; Hu W; Liang S
    J Biol Chem; 2013 Jul; 288(28):20392-403. PubMed ID: 23703613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7.
    Klint JK; Chin YK; Mobli M
    Mol Pharmacol; 2015 Dec; 88(6):1002-10. PubMed ID: 26429937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
    Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
    J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly Discovered Action of HpTx3 from Venom of Heteropoda
    Wu X; Wang Z; Chen Y; Xu D; Zhang P; Wang X
    Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31757020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome.
    Cardoso FC; Castro J; Grundy L; Schober G; Garcia-Caraballo S; Zhao T; Herzig V; King GF; Brierley SM; Lewis RJ
    Pain; 2021 Feb; 162(2):569-581. PubMed ID: 32826759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective Na
    Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
    Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.